BIOPHARMACEUTICALS A GLOBAL MARKET OVERVIEW

Transcription

1 BIOPHARMACEUTICALS A GLOBAL MARKET OVERVIEW The study reviews, analyzes and projects the global market for Biopharmaceuticals for the period PUBLISHED: APRIL 2010 Report Code: BT001 Pages: 240 Charts: 131 Price: $ experts.com

2 INTRODUCTION Biopharma active ingredients are containing in about 50% of the newly approved drugs. The future of biopharmaceuticals is to be projected bright as the market share is growing gradually. In terms of market revenue, out of total pharma market the biopharmaceutical products were accounted for about 10% in 2006 and are projected to account for about 15% by Global Biopharmaceuticals Market Analysis ( ) in USD Million Market The global market for biopharmaceuticals is projected to reach US$182.5 billion by 2015 from an estimated US$63.5 billion in 2006, registering a Compounded Annual Growth Rate (CAGR) of 12.4% during the period USD Million PRODUCT SEGMENTS Oncology Neurology Diabetes Infectious Diseases Cardiovascular REGIONS COVERED North America Western Europe Asia-Pacific Rest of World United States Germany Japan Canada The United Kingdom China France India Italy Rest of Asia-Pacific Spain Rest of Western Europe Glance at 2006, 2010 and 2015 Global Biopharmaceuticals Market Share (%) by Therapeutic Area

3 TABLE OF CONTENTS 1. GLOBAL MARKET PERSPECTIVE Introduction Product Segmentation Monoclonal Antibodies Biotechnology Vaccines Erythropoietin Therapeutic Application Therapeutic Application Recombinant Human Insulin Interferons Human Growth Hormones Therapeutic Application... 6 Anti-Aging Agent... 7 Athletic Advantages... 7 Side Effects Application Analysis Top-25 Biopharmaceutical Blog Buster Drugs Market Trends Big Pharma Companies to Adopt Virtual Pharma Model for Faster Lead Time Biopharmaceutical Research Network for Producing Monoclonal Antibodies European Biopharmaceutical Enterprises to Establish European Biopharmaceutical Innovation Fund Government Policy to Boost Biopharmaceuticals market in China Future Looks Bright for Indian Biopharmaceuticals Market Key Global Players The United States Abbott Laboratories Alexion Pharma Amgen Analytical Biological Services Inc Atlanta Biologicals, Inc AVI BioPharma Baxter Bioscience Corporation BD Biosciences Biogen Idec Bio-Rad Laboratories, Inc DNA Gateway International, Inc Eli Lilly Genentech Genzyme Helix BioPharma Corp. (Canada) Johnson & Johnson Millipore Corporation OSI Pharmaceuticals, Inc Pfizer Inc Procter & Gamble Pharmaceuticals Sigma-Aldrich Corporation Canada Ambrilia Biopharma Inc. (Canada) The United Kingdom AstraZeneca GlaxoSmithKline Pharmaceuticals Limited Switzerland Merck Serono S.A Novartis Roche Germany Bayer AG Sandoz Biogenerics Boehringer Ingelheim Schering Ag France Sanofi-Aventis Denmark Novo Nordisk Belgium Bristol-Myers Squibb Belgium NV UCB S.A Solvay Pharma & Cie China Beijing Tiantan Biological Products Co., Ltd Hualan Biological Engineering Inc India Aventis Pharma Limited Biocon Ltd Cipla Ltd Dr. Reddy s Laboratories Glenmark Pharmaceuticals Ltd GVK BIO Ranbaxy Laboratories Limited Reliance Life Sciences Shantha Biotechniques Ltd Japan Daiichi Sankyo Ltd Takeda Singapore CellResearchCorp South Korea Bukwang Pharma LG Life Sciences Israel Teva Pharmaceutical Industries Key Business Trends February Pharmaxis Takeover Topigen pharma January Astrazeneca Settles Patent Agreement with Teva Pharmaceuticals Molecular Insight Pharmaceuticals reduces personnel to synchronize operations Merz to Bag BioForm Medical December Anika acquires Fidia Advanced Biopolymers Teva-KOWA to acquire stake in Taisho Pharmaceutical Novartis Acquires Corthera Inc AstraZeneca acquires Novexel November BD acquires HandyLab D-Pharm collaborates with Wanbang Biopharmaceuticals GPC Biotech AG merges with Agennix AG October China Biopharmaceuticals merges with NeoStem Bio-Rad signs partnership with Biotest AG for diagnostics Sanofi-Aventis Acquires France based FOVEA September Sandoz Closes acquisition of EBEWE Pharma Sanofi-Aventis Acquires Merck s Interest in Merial July Johnson & Johnson acquires Cougar Biotechnology December Johnson & Johnson acquires Omrix Biopharmaceuticals Inc Teva acquires Barr GlaxoSmithKline acquires BMS Pakistan 46 November Roche signs agreement to takeover Memory Pharmaceuticals Lilly acquires ImClone Systems Acquisition of Alvedon boosts GSK s analgesic portfolio October GSK acquires Genelabs Technologies Novartis Takeover Nektar GSK purchase of Laclede s Biotene September Sanofi Pasteur Acquires Acambis August Lilly takes over SGX Bayer acquires preclinical anti-cancer program from Nycomed July Thermo Fisher takes over FIBERLite Centrifuge Teva Bags Bentley Pharmaceuticals Thermo Fisher Acquires Affinity BioReagents June Intas Biopharma Bags Biologisc Process Development Boehringer Ingelheim acquires Actimis Pharmaceuticals Itero Biopharma collaborates with Biological E. Ltd GVK Bio signs Pact with Wyeth Pharmaceuticals for drug discovery May Takeda acquires Millennium BD Acquires Cytopeia DOR BioPharma Signs Development license agreement with Harvard Abbott Forms Joint Venture with Takeda Takeda acquires Paradigm Therapeutics Thermo Fisher acquires Finnzymes... 54

4 Dr. Reddy s completes two acquisitions EUSA Pharma Acquires Cytogen April Roche acquires Piramed Market Overview by Biopharmaceutical Product Segment Biopharmaceutical Product Market Overview by Global Region Monoclonal Antibodies Biotech Vaccines Erythropoietin Granulocyte-Colony Stimulating Factor Recombinant Human Insulin Interferons Human Growth Hormones Other Biopharmaceuticals Biopharmaceutical Therapeutic Market Overview by Global Region Oncology Neurology Diabetes Infectious Diseases Cardiovascular Other Disease Areas REGIONAL MARKET PERSPECTIVE Regional Market Overview North America Market Overview by North American Region Market Overview by Biopharmaceutical Product Market Overview by Biopharmaceutical Therapeutic Area Biopharmaceutical Product Market Overview by North American Region Monoclonal Antibodies Biotech Vaccines Erythropoietin Granulocyte-Colony Stimulating Factor Recombinant Human Insulin Interferons Major Market Players Abbott Laboratories (USA) Accentia Biopharmaceuticals, Inc. (USA) Advanced Life Sciences, Inc. (USA) Alder Biopharmaceuticals, Inc. (USA) Alexion Pharma (USA) Ambrilia Biopharma Inc. (USA) Amgen (USA) Analytical Biological Services Inc. (USA) Array BioPharma (USA) Astellas Pharma (USA) Atlanta Biologicals, Inc. (USA) AVI BioPharma (USA) Baxter Bioscience Corporation (USA) BD Biosciences (USA) Biodel Inc. (USA) Biogen Idec (USA) Bio-Rad Laboratories, Inc. (USA) DNA Gateway International, Inc. (USA) Eli Lilly (USA) EUSA Pharma (USA) Genentech (USA) Genzyme (USA) Helix BioPharma Corp. (USA) IBI International LLC (USA) Johnson & Johnson's (USA) Millipore Corporation (USA) North American Market Overview by Country The United States Market Overview Canada Market Overview Western Europe Market Overview by Western Europe Region Market Overview by Biopharmaceutical Product Market Overview by Biopharmaceutical Therapeutic Area Biopharmaceutical Product Market Overview by Western Europe Region Monoclonal Antibodies Biotech Vaccines Erythropoietin Recombinant Human Insulin Interferons Human Growth Hormones Other Biopharmaceuticals Major Market Players Agennix AG (Germany) AstraZeneca (United Kingdom) Bayer AG (Germany) Boehringer Ingelheim (Germany) 159 Bristol-Myers Squibb Belgium NV (Belgium) CellGenix Technologie Transfer GmbH (Germany) Western Europe Market Overview by Country Germany Market Overview The United Kingdom Market Overview France Market Overview Italy Market Overview Spain Market Overview Rest of Western Europe Market Overview Asia-Pacific Market Overview by Asia-Pacific Region Market Overview by Biopharmaceutical Therapeutic Area Biopharmaceutical Product Market Overview by Asia-Pacific Region Monoclonal Antibodies Biotech Vaccines Erythropoietin Recombinant Human Insulin Interferons Human Growth Hormones Other Biopharmaceuticals Major Market Players Aurobindo Pharma Ltd. (India) Aventis Pharma Limited (India) Beijing SL Pharmaceutical Co., Ltd. (China) Beijing Tiantan Biological Products Co., Ltd. (China) Biocon Ltd. (India) Biological E Limited (India) Asia-Pacific Market Overview by Country Japan China India Rest of Asia-Pacific Rest of World Market Overview by Biopharmaceutical Product Market Overview by Biopharmaceutical Therapeutic Area Major Market Players GUIDE TO THE INDUSTRY North America United States Canada Europe Germany United Kingdom France Belgium Denmark Ireland Norway Sweden Switzerland The Netherlands Asia-Pacific Japan China India Australia Hong Kong Indonesia Malaysia Singapore South Korea Taiwan Rest of World Brazil Israel

5 LIST OF CHARTS 1. GLOBAL MARKET PERSPECTIVE... 1 Chart 1: Global Biopharmaceuticals Market Analysis ( ) by Therapeutic Area Oncology, Neurology, Diabetes, Infectious Diseases, Cardiovascular and Other in USD Million... 8 Chart 2: Glance at 2006, 2010 and 2015 Global Biopharmaceuticals Market Share (%) by Therapeutic Area Oncology, Neurology, Diabetes, Infectious Diseases, Cardiovascular and Other... 9 Chart 3: Global Sales of Blog Buster Drugs (2008 & 2009) in USD Million Chart 4: Global Biopharmaceuticals Market Analysis ( ) in USD Million Chart 5: Global Biopharmaceuticals Market Analysis ( ) by Product Segment HG Hormones and Other in USD Million Chart 6: Glance at 2006, 2010 and 2015 Global Interferons, HG Hormones and Other Chart 7: Global Monoclonal Antibodies Market Asia-Pacific and Rest of World in USD Million Chart 8: Glance at 2006, 2010 and 2015 Global Monoclonal Antibodies Market Share (%) by Europe, Asia-Pacific and Rest of World Chart 9: Global Biotech Vaccines Market Analysis America, Western Europe, Asia-Pacific and Rest of World in USD Million Chart 10: Glance at 2006, 2010 and 2015 Global Biotech Vaccines Market Share (%) by Geographic Pacific and Rest of World Chart 11: Global Erythropoietin Market Analysis America, Western Europe, Asia-Pacific and Rest of World in USD Million Chart 12: Glance at 2006, 2010 and 2015 Global Erythropoietin Market Share (%) by Geographic Pacific and Rest of World Chart 13: Global G-CSF Market Analysis ( ) by Geographic Region North America, Western Europe, Asia-Pacific and Rest of World in USD Million Chart 14: Glance at 2006, 2010 and 2015 Global G-CSF Market Share (%) by Geographic Region Asia-Pacific and Rest of World Chart 15: Global Monoclonal Antibodies Market Asia-Pacific and Rest of World in USD Million Chart 16: Glance at 2006, 2010 and 2015 Global Monoclonal Antibodies Market Share (%) by Europe, Asia-Pacific and Rest of World Chart 17: Global Interferons Market Analysis America, Western Europe, Asia-Pacific and Rest of World in USD Million Chart 18: Glance at 2006, 2010 and 2015 Global Interferons Market Share (%) by Geographic Pacific and Rest of World Chart 19: Global HG Hormones Market Analysis America, Western Europe, Asia-Pacific and Rest of World in USD Million Chart 20: Glance at 2006, 2010 and 2015 Global HG Hormones Market Share (%) by Geographic Pacific and Rest of World Chart 21: Global Other Biopharmaceuticals Region Asia-Pacific and Rest of World in USD Million Chart 22: Glance at 2006, 2010 and 2015 Global Other Biopharmaceuticals Market Share (%) by Europe, Asia-Pacific and Rest of World Chart 23: Global Biopharmaceuticals Market Analysis ( ) in Oncology by Geographic Pacific and Rest of World in USD Million Chart 24: Glance at 2006, 2010 and 2015 Global Oncology Market Share (%) of Biopharmaceuticals by Europe, Asia-Pacific and Rest of World Chart 25: Global Biopharmaceuticals Market Analysis ( ) in Neurology by Geographic Pacific and Rest of World in USD Million Chart 26: Glance at 2006, 2010 and 2015 Global Neurology Market Share (%) of Biopharmaceuticals by Geographic Region Asia-Pacific and Rest of World Chart 27: Global Biopharmaceuticals Market Analysis ( ) in Diabetes by Geographic Pacific and Rest of World in USD Million Chart 28: Glance at 2006, 2010 and 2015 Global Diabetes Market Share (%) of Biopharmaceuticals by Geographic Region North America, Western Europe, Asia-Pacific and Rest of World Chart 29: Global Biopharmaceuticals Market Analysis ( ) in Infectious Diseases by Europe, Asia-Pacific and Rest of World in USD Million Chart 30: Glance at 2006, 2010 and 2015 Global Infectious Diseases Market Share (%) of Biopharmaceuticals by Geographic Region Asia-Pacific and Rest of World Chart 31: Global Biopharmaceuticals Market Analysis ( ) in Cardiovascular by Europe, Asia-Pacific and Rest of World in USD Million Chart 32: Glance at 2006, 2010 and 2015 Global Cardiovascular Market Share (%) of Biopharmaceuticals by Geographic Region Asia-Pacific and Rest of World Chart 33: Global Biopharmaceuticals Market Analysis ( ) in Other Disease Areas by Geographic Region North America, Western Europe, Asia-Pacific and Rest of World in USD Million Chart 34: Glance at 2006, 2010 and 2015 Global Other Disease Areas Market Share (%) of Biopharmaceuticals by Geographic Region Asia-Pacific and Rest of World REGIONAL MARKET PERSPECTIVE Chart 35: The Projection of Largest Regions in terms of Market Growth for Biopharmaceuticals by Geography Asia-Pacific, Europe and North America Chart 36: Global Biopharmaceuticals Market Asia-Pacific and Rest of World in USD Million Chart 37: Glance at 2006, 2010 and 2015 Global Biopharmaceuticals Market Share (%) by Europe, Asia-Pacific and Rest of World Chart 38: North American Biopharmaceuticals Region United States and Canada in USD Million Chart 39: Glance at 2006, 2010 and 2015 North American Biopharmaceuticals Market Share (%) by Canada Chart 40: North American Biopharmaceuticals HG Hormones and Other in USD Million Chart 41: Glance at 2006, 2010 and 2015 North American Biopharmaceuticals Market Share (%) by Product Vaccines, Erythropoietin, G-CSF, RH Insulin,Interferons, HG Hormones and Other Chart 42: North American Biopharmaceuticals Market Analysis ( ) by Therapeutic Area Oncology, Neurology, Diabetes, Infectious Diseases, Cardiovascular and Other in USD Million

6 Chart 43: Glance at 2006, 2010 and 2015 North American Biopharmaceuticals Market Share (%) by Therapeutic Area Oncology, Neurology, Diabetes, Infectious Diseases, Cardiovascular and Other Chart 44: North American Monoclonal Antibodies Market ( ) by Geographic Region United States and Canada in USD Million Chart 45: Glance at 2006, 2010 and 2015 North American Monoclonal Antibodies Market Share (%) by Canada Chart 46: North American Biotech Vaccines Region United States and Canada in USD Million Chart 47: Glance at 2006, 2010 and 2015 North American Biotech Vaccines Market Share (%) by Canada Chart 48: North American Erythropoietin Market United States and Canada in USD Million Chart 49: Glance at 2006, 2010 and 2015 North American Erythropoietin Market Share (%) by Canada Chart 50: North American G-CSF Market Analysis ( ) by Geographic Region United States and Canada in USD Million Chart 51: Glance at 2006, 2010 and 2015 North American G-CSF Market Share (%) by Geographic Region United States and Canada Chart 52: North American RH Insulin Market Analysis ( ) by Geographic Region United States and Canada in USD Million Chart 53: Glance at 2006, 2010 and 2015 North American RH Insulin Market Share (%) by Canada Chart 54: North American Interferons Market United States and Canada in USD Million Chart 55: Glance at 2006, 2010 and 2015 North American Interferons Market Share (%) by Canada Chart 56: North American HG Hormones Market United States and Canada in USD Million Chart 57: Glance at 2006, 2010 and 2015 North American HG Hormones Market Share (%) by Canada Chart 58: North American Other Biopharmaceuticals Market Analysis ( ) by Canada in USD Million Chart 59: Glance at 2006, 2010 and 2015 North American Other Biopharmaceuticals Market Share (%) by Geographic Region United States and Canada Chart 60: United States Biopharmaceuticals HG Hormones and Other in USD Million Chart 61: Glance at 2006, 2010 and 2015 United States Biopharmaceuticals Market Share (%) by Product Interferons, HG Hormones and Other Chart 62: Canadian Biopharmaceuticals Market HG Hormones and Other in USD Million Chart 63: Glance at 2006, 2010 and 2015 Canadian Interferons, HG Hormones and Other Chart 64: Western Europe Biopharmaceuticals Spain and Rest of WE in USD Million Chart 65: Glance at 2006, 2010 and 2015 Western Europe Biopharmaceuticals Market Share (%) by France, Italy, Spain and Rest of WE Chart 66: Western Europe Biopharmaceuticals HG Hormones and Other in USD Million Chart 67: Glance at 2006, 2010 and 2015 Western Europe Biopharmaceuticals Market Share (%) by Product Interferons, HG Hormones and Other Chart 68: Western Europe Biopharmaceuticals Market Analysis ( ) by Therapeutic Area Oncology, Neurology, Diabetes, Infectious Diseases, Cardiovascular and Other in USD Million Chart 69: Glance at 2006, 2010 and 2015 Western Europe Biopharmaceuticals Market Share (%) by Therapeutic Area Oncology, Neurology, Diabetes, Infectious Diseases, Cardiovascular and Other Chart 70: Western Europe Monoclonal Antibodies Spain and Rest of WE in USD Million Chart 71: Glance at 2006, 2010 and 2015 Western Europe Monoclonal Antibodies Market Share (%) by Geographic Region Germany, United Kingdom, France, Italy, Spain and Rest of WE Chart 72: Western Europe Biotech Vaccines Spain and Rest of WE in USD Million Chart 73: Glance at 2006, 2010 and 2015 Western Europe Biotech Vaccines Market Share (%) by France, Italy, Spain and Rest of WE Chart 74: Western Europe Erythropoietin Market Germany, United Kingdom, France, Italy, Spain and Rest of WE in USD Million Chart 75: Glance at 2006, 2010 and 2015 Western Europe Erythropoietin Market Share (%) by Geographic Region Germany, United Kingdom, France, Italy, Spain and Rest of WE Chart 76: Western Europe G-CSF Market Analysis ( ) by Geographic Region Germany, United Kingdom, France, Italy, Spain and Rest of WE in USD Million Chart 77: Glance at 2006, 2010 and 2015 Western Europe G-CSF Market Share (%) by Geographic Spain and Rest of WE Chart 78: Western Europe RH Insulin Market Germany, United Kingdom, France, Italy, Spain and Rest of WE in USD Million Chart 79: Glance at 2006, 2010 and 2015 Western Europe RH Insulin Market Share (%) by France, Italy, Spain and Rest of WE Chart 80: Western Europe Interferons Market Germany, United Kingdom, France, Italy, Spain and Rest of WE in USD Million Chart 81: Glance at 2006, 2010 and 2015 Western Europe Interferons Market Share (%) by France, Italy, Spain and Rest of WE Chart 82: Western Europe HG Hormones Market Germany, United Kingdom, France, Italy, Spain and Rest of WE in USD Million Chart 83: Glance at 2006, 2010 and 2015 Western Europe HG Hormones Market Share (%) by France, Italy, Spain and Rest of WE Chart 84: Western Europe Other Biopharmaceuticals Market Germany, United Kingdom, France, Italy, Spain and Rest of WE in USD Million Chart 85: Glance at 2006, 2010 and 2015 Western Europe Other Biopharmaceuticals Market Share (%) by Geographic Region Germany, United Kingdom, France, Italy, Spain and Rest of WE 157 Chart 86: German Biopharmaceuticals Market HG Hormones and Other in USD Million Chart 87: Glance at 2006, 2010 and 2015 German Interferons, HG Hormones and Other Chart 88: United Kingdom Biopharmaceuticals HG Hormones and Other in USD Million For enquires please contact at

7 Chart 89: Glance at 2006, 2010 and 2015 United Kingdom Biopharmaceuticals Market Share (%) by Product Segment Monoclonal Antibodies, Biotech Interferons, HG Hormones and Other Chart 90: French Biopharmaceuticals Market HG Hormones and Other in USD Million Chart 91: Glance at 2006, 2010 and 2015 French Interferons, HG Hormones and Other Chart 92: Italian Biopharmaceuticals Market HG Hormones and Other in USD Million Chart 93: Glance at 2006, 2010 and 2015 Italian Interferons, HG Hormones and Other Chart 94: Spanish Biopharmaceuticals Market HG Hormones and Other in USD Million Chart 95: Glance at 2006, 2010 and 2015 Spanish Interferons, HG Hormones and Other MAJOR COMPANIES PROFILED Abbott Laboratories Amgen AstraZeneca Bayer AG BD Biosciences Bio-Rad Laboratories Bristol-Myers Squibb China Biopharmaceuticals Holdings, Inc. Daiichi Sankyo Dr Reddy's Group Dr.Reddy s Laboratories Ltd Eli Lilly Genentech GlaxoSmithKline plc Johnson & Johnson Millennium Pharmaceuticals Novartis Pfizer Inc. Reliance Life Sciences Pvt. Ltd. Roche Sanofi-Aventis Schering Ag Takeda Thermo Fisher Scientific, Inc Wyeth Pharmaceuticals. Chart 96: Rest of WE Biopharmaceuticals Market HG Hormones and Other in USD Million Chart 97: Glance at 2006, 2010 and 2015 Rest of WE Biopharmaceuticals Market Share (%) by Product Segment Monoclonal Antibodies, Biotech Interferons, HG Hormones and Other Chart 98: Asia-Pacific Biopharmaceuticals Market Japan, China, India and Rest of Asia-Pacific in USD Million Chart 99: Glance at 2006, 2010 and 2015 Asia- Pacific Biopharmaceuticals Market Share (%) by Geographic Region Japan, China, India and Rest of Asia-Pacific Chart 100: Asia-Pacific Biopharmaceuticals HG Hormones and Other in USD Million Chart 101: Glance at 2006, 2010 and 2015 Asia- Pacific Biopharmaceuticals Market Share (%) by Product Interferons, HG Hormones and Other Chart 102: Asia-Pacific Biopharmaceuticals Market Analysis ( ) by Therapeutic Area Oncology, Neurology, Diabetes, Infectious Diseases, Cardiovascular and Other in USD Million Chart 103: Glance at 2006, 2010 and 2015 Asia- Pacific Biopharmaceuticals Market Share (%) by Therapeutic Area Oncology, Neurology, Diabetes, Infectious Diseases, Cardiovascular and Other Chart 104: Asia-Pacific Monoclonal Antibodies Region Japan, China, India and Rest of Asia- Pacific in USD Million Chart 105: Glance at 2006, 2010 and 2015 Asia- Pacific Monoclonal Antibodies Market Share (%) by Geographic Region Japan, China, India and Rest of Asia-Pacific Chart 106: Asia-Pacific Biotech Vaccines Market Japan, China, India and Rest of Asia-Pacific in USD Million Chart 107: Glance at 2006, 2010 and 2015 Asia- Pacific Biotech Vaccines Market Share (%) by Geographic Region Japan, China, India and Rest of Asia-Pacific MAJOR MARKET PLAYERS This study profiles 53 key global players and 87 major players across North America 37; Western Europe 18; Asia-Pacific 30; and Rest of World 2. The report also provides the listing of the companies engaged in research, technology development, manufacturing and the supply of biopharmaceuticals. The global list of companies covers addresses, contact numbers and the website addresses of 382 companies. Global Sales of Blog Buster Drugs (2008 & 2009) in USD Million Drug Company 2008 Sales 2009 Sales Neulasta /NEUPOGEN Amgen X.XXX X.XXX ENBREL Amgen X.XXX X.XXX Aranesp Amgen X.XXX X.XXX Avastin Genentech X.XXX X.XXX Rituxan Genentech X.XXX X.XXX EPOGEN Amgen X.XXX X.XXX AVONEX Biogen Idec X.XXX X.XXX Keppra UCB X.XXX X.XXX Herceptin Genentech X.XXX X.XXX Cerezyme Genzyme X.XXX X.XXX. KEY TRENDS Pharmaceutical industry, with automation, is witnessing rapid advances. Most of them are outsourcing their manufacturing process to Contract Manufacturing Organizations (CMO) which said to have integrated themselves.. Biopharmaceutical industry in china is entering a new era which in words of some experts known to be a golden era. It is more due to the five-year plan by the Chinese central government that the biopharmaceutical industry in near future is more likely to... Click here to purchase this report online